CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	May 31, 2012	Nov. 30, 2011
ASSETS
Cash and cash equivalents	$ 335,853	$ 405,327
Grant receivable	0	303,102
Other current assets	9,611	10,598
Total current assets	345,464	719,027
Property and equipment, net of accumulated depreciation of $66,467	0	0
Other assets	1,685	1,685
Total assets	347,149	720,712
LIABILITIES AND EQUITY (DEFICIENCY)
Accounts payable and accrued expenses	1,274,470	1,304,422
Payable to related party	50,000	50,000
Advance from debenture holder	108,035	301,930
Current portion of deferred revenue	49,318	49,318
Total current liabilities	1,481,823	1,705,670
Non-current liabilities
Convertible debentures, net of discount	60,086	59,596
Deferred revenue, net of current portion	523,400	548,059
Derivative liability related to Series B convertible preferred stock	117,022	160,986
Total non-current liabilities	700,508	768,641
Total liabilities	2,182,331	2,474,311
Commitments and contingencies	0	0
Equity (Deficiency)
Preferred stock	0	0
Common stock, $0.01 par value; 1,250,000,000 shares authorized; 968,128,480 and 823,385,986 shares issued and outstanding at May 31, 2012 and November 30, 2011, respectively	9,681,285	8,233,860
Additional paid-in capital	29,234,010	30,064,619
Accumulated deficit	(41,647,673)	(40,998,344)
Total MultiCell Technologies, Inc. stockholders' equity (deficiency)	(809,134)	(776,621)
Noncontrolling interests	(1,026,048)	(976,978)
Total equity (deficiency)	(1,835,182)	(1,753,599)
Total liabilities and equity (deficiency)	347,149	720,712
Series B Convertible Preferred Stock [Member]
Equity (Deficiency)
Preferred stock	1,349,844	1,349,844
Series I Convertible Preferred Stock [Member]
Equity (Deficiency)
Preferred stock	$ 573,400	$ 573,400